Clinical Trial Update: CoQ10 and D-ribose in Patients With Diastolic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CoQ10 and D-ribose in diastolic heart failure completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure
• Heart Failure

Drugs mentioned

• CoQ10 (ubiquinol/Coenzyme Q10) (coenzyme Q10)
• D-ribose (D-ribose)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Heart Failure, Diastolic | Phase 2 | Status: COMPLETED | Results posted: 2022-03-03